Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Healthcare

AstraZeneca Pauses Coronavirus Vaccine Trial As Participant Illness Investigated

Germany's Leukocare, which is working on a vaccine similar to AstraZeneca's but at an earlier stage, agreed that safety issues are likely to crop up in large trials.

Read More

Telemedicine Market In India To Reach $5.5 Bn by 2025: EY-IPA study

Virtual care consists of tele–consult, telepathology, teleradiology and e–pharmacy and is experiencing an encouraging stimulus in India due to the pandemic

Read More

Healthcare M&A Outlook – De-Risking Through Self-Reliance And Market Consolidation

The healthcare companies are expected to collaborate across verticals to provide value-based healthcare based on the go to patient approach and adopt cloud-based electronic health records, virtual consultation and tele-medicine channels in expanding emerging markets.

Read More

Healthcare Is Now Getting The Attention It Deserves: GSK Velu, Chairman & Managing Director, Trivitron Healthcare

Today, most people prefer getting blood tests done from home. And now we are offering even ECGs at home. X-rays too can be done at home. This trend will only increase

Read More

Sanofi, GSK Launch Trial For COVID-19 Protein-based Vaccine

If the results are conclusive, Sanofi and GSK hope to get the vaccine approved in the first half of next year.

Read More

Capgemini Sees Double-Digit 2020 Revenue Growth, Second-Half Recovery

Capgemini rival Accenture narrowed its fiscal 2020 revenue growth forecast to between 3.5% and 4.5% amid the coronavirus-fueled economic slump.

Read More

Digitization In Healthcare, The Revolution India Is Going To Experience Post COVID-19

Healthcare experts strongly recommend that patients should seek second opinion from specialists before taking next steps for any critical and complicated procedure.

Read More

We Aim To Enhance Efficiency Of The Healthcare System In India: Dr. Praveen Gedam, Addl CEO, NHA

In conversation with BusinessWorld, Dr. Praveen Gedam, Additional CEO, National Health Authority (NHA) talks about National Digital Health Mission, NHA’s progressive mission that is all set to revolutionise India’s Healthcare system.

Read More

Zydus Cadila Gets USFDA Nod For Muscle Relaxant Injection

The group now has 297 approvals and has so far filed over 390 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04.

Read More

Religare Health Insurance rebrands as Care Health Insurance

Effective September 1, the rebranding is an adoption of its principal deliverable ‘Care’, the company said. Except the name, Care Health Insurance’s founding management team, value-for-money products and the technology-driven servicing capabilities are all the same, it added.

Read More

Importance And Benefits Of Drinking Purified Water For Better Immunity

A recent study has revealed how certain areas in hospitals contained more viruses and how an increasing number of healthcare workers themselves get infected with the deadly virus.

Read More

Moderna COVID-19 Vaccine Appears To Work As Well In Older Adults In Early Study

Health officials have been concerned about whether vaccine candidates would work in older people, whose immune systems typically do not respond as strongly to vaccines.

Read More

How Will The Current Pandemic Change The Face Of Healthcare?

COVID-19 has opened the Pandora’s Box for players with the impact clearly visible on the functioning models and financial health.

Read More

Takeda To Sell Japan Consumer Health Unit Valued At $2.3 Billion To Blackstone

Japan's largest pharmaceuticals company has been reducing its OTC assets worldwide as it seeks to refocus its business and reduce debt following its $59 billion acquisition of Shire.

Read More

Novartis Immuno-Oncology Drug Candidate Fails Skin Cancer Trial

The drug did not improve progression-free survival in previously untreated patients with BRAF V600 mutation-positive cutaneous melanoma, compared to Tafinlar + Mekinist alone, Novartis said.

Read More